XML 47 R41.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Financial Statement Details - Schedule of Liability Related to Sale of Potential Future Royalties (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
 [1]
Sep. 30, 2025
Sep. 30, 2024
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Liabilities related to the sales of future royalties, net – beginning balance     $ 91,776  
Non-cash royalty revenue     (33,125) $ (48,029)
Non-cash interest expense $ 6,047 $ 6,020 16,415 $ 17,959 [1]
Amortization of transaction costs     98  
Liabilities related to the sales of future royalties, net – ending balance 75,164   75,164  
2012 Purchase and Sale Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Liabilities related to the sales of future royalties, net – beginning balance     7,197  
Non-cash royalty revenue     (5,619)  
Non-cash interest expense     1,983  
Amortization of transaction costs     0  
Liabilities related to the sales of future royalties, net – ending balance 3,561   3,561  
2020 Purchase and Sale Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Liabilities related to the sales of future royalties, net – beginning balance     84,579  
Non-cash royalty revenue     (27,506)  
Non-cash interest expense     14,432  
Amortization of transaction costs     98  
Liabilities related to the sales of future royalties, net – ending balance $ 71,603   $ 71,603  
[1] All share and per share amounts have been retrospectively adjusted to reflect a one-for-fifteen reverse stock split (see Note 6).